VANCOUVER, BC — Renaissance BioScience (RBSC), a leader in bioengineering, is pleased to announce that it has strategically partnered with the Vaccine and Infectious Disease Organization (VIDO), a world leader… Read More
BRUKINSA is now listed on the RAMQ and ODB formularies. Two global Phase 3 trials in adults with CLL demonstrated superior efficacy for BRUKINSA in first line and relapsed/refractory settings…. Read More
VAUGHAN, ON – BFC Technologies Inc. (BFC) is celebrating 20 years in business as a preferred supplier of integrated process solutions in North America. When Dave Eccleston and Ron Lalonde… Read More
Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from baseline in both the abdominoplasty and bunionectomy… Read More
The company’s impressive pipeline of medicines & vaccines positions it to continue creating positive health outcomes for patients for another century and beyond TORONTO, ON – Sanofi, a global healthcare… Read More
